(2026). Peripheral blood IFN-γ–producing T-cell subsets and soluble IL-2 receptor as independent prognostic biomarkers in NSCLC treated with immune checkpoint inhibitor–based therapy. Discover Oncology.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Peripheral Blood IFN-γ–producing T-cell Subsets and Soluble IL-2 Receptor as Independent Prognostic Biomarkers in NSCLC Treated with Immune Checkpoint Inhibitor–based Therapy."
Discover Oncology 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Peripheral Blood IFN-γ–producing T-cell Subsets and Soluble IL-2 Receptor as Independent Prognostic Biomarkers in NSCLC Treated with Immune Checkpoint Inhibitor–based Therapy."
Discover Oncology, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.